Administration of FN significantly inhibited S. pneumoniae corneal infection in a dose-dependent manner, and at the highest dose tested, FN had a similar inhibitory effect as that of purified Sdc1 ectodomains where the corneal bacterial burden was decreased by more than 95% compared to control (Fig. 6A). This evidence concerns the gene SDC1 and pneumonia.